Letters, Testimony & Filings What is the FDA’s Role in the Development of New Antibiotics?: The Case of Recarbrio January 1, 2024
Letters, Testimony & Filings Comment regarding the FDA’s proposed funding of the RADARS drug abuse surveillance system December 18, 2023
Fact Sheets & Backgrounders Expanding Access and Affordability to Taxpayer Funded Drugs: The Use of March-In Rights
Press Releases New Public Citizen Petition Asks FDA for Stronger Safety Warnings for Botox and Related Drugs December 12, 2023
Letters, Testimony & Filings Petition to the FDA to Strengthen Safety Warning for Botox and Related Drugs and Remove Misleading Claims From Botox/Botox Cosmetic Labeling December 12, 2023